StocksMedium•3 November 2026•
1 min read
Stevanato Group Reports 8% Revenue Growth in Q3 2026
Key Facts
1Stevanato Group revenue increased 8% to €326.1 million in the third quarter of 2026.
Stevanato Group revenue increased 8% to €326.1 million in the third quarter of 2026. Business Wire reported that the growth reflected an increase in both total and organic revenue for the fiscal period.
The performance was driven by the company's drug containment and delivery solutions, with high-value solutions contributing significantly to the revenue mix. STVN closed at $19.74 on November 2, 2026, ahead of the financial results announcement.